Cofirasersen
Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
For research use only. We do not sell to patients.
- CAS No.: 2247669-96-9
- Formula: C172H218N57O88P15S15
- Molecular Weight:5437.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 2247669-96-9
-
Molecular Weight 5437.55
-
Formula C172H218N57O88P15S15
-
SMILES
[Cofirasersen]
-
Synonyms
ION-827359
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)